Skin Neoplasms Clinical Trial
Official title:
Diagnosis of Non-Melanoma Skin Cancer With Optical Coherence Tomography
We will do systematic and functional assessment of non-melanoma skin cancer including precancerous lesions by OCT imaging and other diagnostic methods. The systematic assessment will be comparison of clinical diagnosis, histopathology, OCT images, spectrophotometry and high frequency ultrasound of non-melanoma skin cancer Functional exploration of non-melanoma skin cancer is done with Doppler-OCT and polarization-sensitive-OCT.
Optimal management of skin malignancies relies on early and accurate diagnosis. The
reference standard in skin cancer is biopsy and histopathological assessment from a clinical
suspicious skin lesion. The clinical diagnosis of skin cancer has sensitivity ranging from
50% to 90 % and specificity around 70% to 80% depending on the population studied and the
experience of the clinician.
A rapid, non-invasive technique that could be used for characterization of skin lesions
prior to biopsy would be valuable. In some patients with multiple, recurrent skin tumours
the need for numerous biopsies in the same area is problematic, both cosmetically and
diagnostically, as the cancer can be hidden under scar tissue.
The biopsy has several weaknesses: The biopsy must be done exactly in the tumour, and it
does not delineate the tumour borders. Biopsy from skin is in general easy, but there are
problematic places such as the T-zone in the face, the eyelids and the ears. Notably these
places are areas where most types of skin cancer exhibit aggressive, invasive growth and
have a high recurrence rate.
OCT is a novel, non-invasive optical imaging technology. It can provide cross-sectional
tomographic images of tissue pathology in situ and in real time, without the need for
excision and processing of specimens, as in conventional histopathology. OCT uses harmless,
infrared light to create high-resolution images of tissue. OCT provides cross-sectional
images of structures below the tissue surface in analogy to histopathology. Hence OCT can
function as an “optical biopsy” providing images of tissue structure on the micron scale.
For example, OCT could be used where standard excisional biopsy is hazardous or impossible,
and OCT could reduce sampling errors associated with excisional biopsy.
;
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00027586 -
Imatinib Mesylate in Treating Patients With Metastatic Melanoma
|
Phase 2 | |
Not yet recruiting |
NCT02230462 -
Patient Satisfaction After Facial Reconstruction
|
N/A | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Completed |
NCT00224744 -
Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage
|
Phase 3 | |
Completed |
NCT03132012 -
Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection
|
N/A | |
Terminated |
NCT00865878 -
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
|
Phase 2 | |
Not yet recruiting |
NCT05359419 -
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
|
Phase 4 | |
Active, not recruiting |
NCT00001813 -
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
|
||
Completed |
NCT02046811 -
Reducing Skin Cancer Risk in Childhood Cancer Survivors
|
N/A | |
Completed |
NCT02147080 -
A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults
|
N/A | |
Completed |
NCT00007631 -
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
|
Phase 3 | |
Completed |
NCT00847912 -
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
|
Phase 4 | |
Recruiting |
NCT02836548 -
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
|
Phase 1/Phase 2 | |
Completed |
NCT01482104 -
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
|
N/A | |
Enrolling by invitation |
NCT04630886 -
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
|
Early Phase 1 | |
Completed |
NCT03012581 -
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
|
Phase 2 | |
Withdrawn |
NCT02813902 -
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
|
Phase 1 | |
Not yet recruiting |
NCT02408835 -
Negative Pressure Wound Therapy in Groin Dissection
|
N/A | |
Completed |
NCT00204789 -
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
|
Phase 2 | |
Completed |
NCT02310503 -
Spanish Registry of Mohs Surgery
|